A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 361-8609, Iss. 10, 2015-10 ,pp. : 877-881

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia

By Kotasek Dusan   Canon Jean-Luc   Mateos Maria Victoria   Hedenus Michael   Rossi Greg   Taylor Kerry  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1387-1401

Informa Healthcare

Access to resources Recommend Favorite

Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia

By Henry David H.   Gordan Lucio N.   Charu Veena   Wilhelm Francois E.   Williams Denise   Xie John   Woodman Richard C.  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1403-1413

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced anemia: the story of darbepoetin alfa

By Vansteenkiste Johan   Wauters Isabelle   Elliott Steven   Glaspy John   Hedenus Michael  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 325-337

Informa Healthcare

Access to resources Recommend Favorite

A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia

By Ray-Coquard I.   Laplaige P.   Vey N.   Asselain B.   Urbieta M.  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2653-2660

Informa Healthcare

Access to resources Recommend Favorite